Immunomodulatory therapy of eosinophil-associated gastrointestinal diseases. - Wikidata - wikimedia - TriplyDB

Immunomodulatory therapy of eosinophil-associated gastrointestinal diseases.

Immunomodulatory therapy of eosinophil-associated gastrointestinal diseases.

http://www.wikidata.org/entity/Q37336072

about

Non-surgical interventions for eosinophilic esophagitis Eosinophilic gastroenteritis: Approach to diagnosis and management Changing roles of eosinophils in health and disease.Biology and treatment of eosinophilic esophagitis.IgE-Related Chronic Diseases and Anti-IgE-Based Treatments.Thymic stromal lymphopoietin-elicited basophil responses promote eosinophilic esophagitis.Eosinophilic diseases of the gastrointestinal tract.Eosinophilic gastrointestinal disorders (EGID) with peripheral eosinophilia: a retrospective review at Mayo Clinic.Molecular and clinical rationale for therapeutic targeting of interleukin-5 and its receptor.Novel approaches to food allergy.Anti-IgE--emerging opportunities for Omalizumab.An overview of the effects of anti-IgE therapies.The management of eosinophilic gastroenteritis.Pharmacological treatment of eosinophilic gastrointestinal disorders.Advances in anti-IgE therapy Omalizumab in the treatment of eosinophilic esophagitis and food allergy.Eosinophilic oesophagitis: an emerging clinical condition.

P2860

Q24236562-BD3F8739-3A91-4B78-AB7A-EE67A9473979 Q28080275-CC7F81C6-06B6-4234-A854-D32B1383268F Q33787311-D07B29F4-366F-46AB-848E-A53F970B460C Q37549336-D87D6318-D3C1-4375-8783-86044E0234C8 Q37554168-F11DD53D-AB46-41F8-A533-312CC4A93B93 Q37632813-02D1EDF4-0935-49E5-BCF9-C97BF1FDCC8E Q37761380-EFE7A2D0-D9C4-413B-B79A-5B12F6BCD692 Q37886794-6DF2C1FD-8373-4970-B590-DA46212AAD2B Q37957225-3D26E23C-8FE1-4244-99BA-D5DE08973241 Q38074866-DF5AC4F9-08E9-472D-9AA0-3170B93A46D1 Q38091754-D9820450-ADF7-402C-BBF7-EB358AABA930 Q38252958-B83A609F-417F-47E3-BE64-62643EEAD005 Q38509377-D0E8BF43-FE2F-4134-8D47-56DAF5F47C50 Q38837172-BBA45204-61AE-4314-99E4-567B0D5059E8 Q40812061-01311A8F-C470-4B39-A79E-F76C5C61F4C5 Q48619297-378E75C5-12A8-4F03-9BB0-7E8C4DFF620F Q55633984-C771B12B-CA4D-4199-AB91-0FB6E584C2A4

P2860

Immunomodulatory therapy of eosinophil-associated gastrointestinal diseases.

http://www.wikidata.org/entity/Q37336072

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Immunomodulatory therapy of eosinophil-associated gastrointestinal diseases.

@en

Immunomodulatory therapy of eosinophil-associated gastrointestinal diseases.

@nl

type

label

Immunomodulatory therapy of eosinophil-associated gastrointestinal diseases.

@en

Immunomodulatory therapy of eosinophil-associated gastrointestinal diseases.

@nl

prefLabel

Immunomodulatory therapy of eosinophil-associated gastrointestinal diseases.

@en

Immunomodulatory therapy of eosinophil-associated gastrointestinal diseases.

@nl

P1433

Q37336072-9D4D3E71-1AA5-432A-96F7-0A616E217F5C

P1476

Q37336072-2E54A082-9E16-4523-AACD-A5C9CDAAAA2E

P2093

Q37336072-A98B9DCE-8DE9-4573-B68C-03C0E245FE8F

P2860

Q37336072-04BD2330-33A5-4840-96F8-354ADDFC677C

Q37336072-2DE8F411-7006-437F-B7D3-CBC0C8CB0A2E

Q37336072-31399639-C6F0-491F-ABED-B4CC357E9288

Q37336072-3F2754BA-CDAF-456C-84E5-8E18DA5FBE69

Q37336072-406C3193-0F26-49C5-A707-6E0C658194C9

Q37336072-45C8F331-92D4-4E81-99AD-C73B7AC6AB5A

Q37336072-4E37DFC8-3875-4EF3-A3DF-0497B39A7187

Q37336072-506F53C5-5628-4815-9BCA-034E3AC468D1

Q37336072-5A10044E-4324-4B3B-86CA-9586E68F1766

Q37336072-6628C567-9943-49E4-AE2F-7D1AB5E8F0EF

P304

Q37336072-50544AC0-C4E7-4CEB-9532-F6D17AB0A2B6

P31

Q37336072-869D27FA-5EDE-4626-A746-7E0BC995E715

P356

Q37336072-F56BE993-AD5F-4053-B1E7-C096F208AC37

P433

Q37336072-93A3B733-BF59-420D-8AD5-ED81B0FF4959

P478

Q37336072-BD781A07-118A-457C-B680-B1EC18970740

P50

Q37336072-6D6EF529-A8A1-48F7-80FF-9403A68677B9

P577

Q37336072-2F7568E9-A1E5-4F4D-9552-A7FEC7EEC443

P5875

Q37336072-857FE7DA-4D41-42DF-BC68-EE910E899FEF

P698

Q37336072-EB7E2505-F668-4C10-AB2A-C0B02A2151D3

P932

Q37336072-0BB2EDD8-619E-4148-A9CB-02FD6DD4AA4A

P356

J.1365-2222.2008.03122.X

P1433

Clinical & Experimental Allergy

P1476

Immunomodulatory therapy of eosinophil-associated gastrointestinal diseases

@en

P2093

K D Stone

http://www.w3.org/2001/XMLSchema#string

P2860

Basic pathogenesis of eosinophilic esophagitis

An etiological role for aeroallergens and eosinophils in experimental esophagitis

Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment

Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis

The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation.

Treatment of patients with the hypereosinophilic syndrome with mepolizumab.

Pharmacodynamics of omalizumab: implications for optimised dosing strategies and clinical efficacy in the treatment of allergic asthma.

Eosinophilic gastrointestinal disorders (EGID).

Anti-interleukin-5 therapy for asthma and hypereosinophilic syndrome.

Eosinophil trafficking in allergy and asthma.

P304

1858-1865

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2222.2008.03122.X

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23501744

http://www.w3.org/2001/XMLSchema#string

P698

19037962

http://www.w3.org/2001/XMLSchema#string

P932

2768622

http://www.w3.org/2001/XMLSchema#string